Strongbridge Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STRONGBRIDGE, and when can generic versions of STRONGBRIDGE drugs launch?
STRONGBRIDGE has one approved drug.
There are eight US patents protecting STRONGBRIDGE drugs.
There are twenty-nine patent family members on STRONGBRIDGE drugs in twenty-one countries.
Drugs and US Patents for Strongbridge
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 10,098,877 | ⤷ Subscribe | ⤷ Subscribe | ||||
Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 11,903,940 | ⤷ Subscribe | ⤷ Subscribe | ||||
Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 9,918,984 | ⤷ Subscribe | ⤷ Subscribe | ||||
Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 11,478,471 | ⤷ Subscribe | ⤷ Subscribe | ||||
Strongbridge | RECORLEV | levoketoconazole | TABLET;ORAL | 214133-001 | Dec 30, 2021 | RX | Yes | Yes | 10,517,868 | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Strongbridge Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
New Zealand | 560481 | ⤷ Subscribe |
European Patent Office | 1853266 | ⤷ Subscribe |
South Korea | 101387910 | ⤷ Subscribe |
European Patent Office | 3934649 | ⤷ Subscribe |
Israel | 184459 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.